Amalgamated Bank Corbus Pharmaceuticals Holdings, Inc. Transaction History

Amalgamated Bank

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$1.39 - $2.21 $16,132 - $25,649	-11,606 Closed	0 $0
Q3 2020 Oct 30, 2020	BUY	$1.5 - $9.38 $1,573 - $9,839	1,049 Added 9.94%	11,606 $21,000
Q2 2020 Aug 10, 2020	SELL	$4.79 - $8.39 $780 - $1,367	-163 Reduced 1.52%	10,557 $89,000
Q1 2020 May 13, 2020	SELL	$3.44 - $7.21 $1,806 - $3,785	-525 Reduced 4.67%	10,720 $56,000
Q4 2019 Feb 13, 2020	BUY	$4.29 - $5.64 $2,668 - $3,508	622 Added 5.86%	11,245 $61,000
Q3 2019 Nov 13, 2019	SELL	$4.87 - $7.08 $399 - $580	-82 Reduced 0.77%	10,623 $52,000
Q2 2019 Aug 14, 2019	BUY	$6.6 - $7.8 $70,653 - $83,499	10,705 New	10,705 $74,000

38.7K

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $2.08B
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

Stay updated on Amalgamated Bank with notifications on news.